ALLERGY CARE

OXRIZINE LC™

Complex Allergic-Inflammatory Management

Levocetirizine Hydrochloride 5mg & Montelukast Sodium 10mg Bi-Layered Tablets for dual-pathway, 24-hour symptom freedom.

WHO-GMP CERTIFIED

ISO 9001 CERTIFIED

QUALITY ASSURED

SCHEDULE H PRESCRIPTION

Dosage Form Film Coated Tablets

Pack Size 10 x 10 Tablets (Alu-Alu)

Storage Store below 25°C. Protect from light & moisture.

Shelf Life 24 Months from the date of manufacture

Prescription Schedule H Prescription Medicine

COMPOSITION

Each Bi-Layered Tablet Contains

Levocetirizine Hydrochloride IP 5.0 mg

Montelukast Sodium IP 10.0 mg

Bi-Layered Excipients q.s.

KEY BENEFITS

01

Dual-Pathway Control

Inhibits histamine H1 receptors and leukotriene cascades.

02

Superior Decongestion

Clears nasal airway inflammation and mucosal edema.

03

Broad Efficacy

Relieves perennial and seasonal allergic rhinitis symptoms.

04

All-Day & Night Relief

Sustained 24-hour symptom relief with once-daily dosing.

DOSAGE

One tablet daily in the evening, or as directed by Physician.

STORAGE

Store below 25°C.

Protect from light and moisture.

PRESCRIPTION

Schedule H Prescription Medicine. To be sold by retail on the prescription of a Registered Medical Practitioner only.

ABOUT OXRIZINE LC™

OXRIZINE LC™ combines a non-sedating H1-receptor antagonist with a leukotriene receptor antagonist in a bi-layered tablet for comprehensive upper respiratory allergic control.

DUAL PATHWAY

Targets both early histamine & late leukotriene cascades.

AIRWAY CLEARANCE

Prevents bronchoconstriction and nasal obstruction.

BI-LAYERED TECH

Precision drug release format for 24-hour symptom relief.

QUALITY CERTIFIED

Formulated under WHO-GMP & ISO 9001 certified protocols.